Offering Pioneering Advancements in Brain repair pharmaceutical technology against neurodegeneration

Levadopa was introduced more than 65 years ago as a pioneer therapeutic for brain motor and cognitive decline symptom management in Parkinson’s disease patients, and its variants targeting cognitive decline. Unfortunately, Levadopa developments, and its pharmaceutics have not offered brain repair solutions against neurodegeneration.

CNS Curative Technologies has made advancements in research and development in pharmaceutical grade nasal nootropic technologies re-enabling neuronal mechanisms of actions for increased signaling in: cognitive, memory, and motor capabilities aimed for neurological conditions with low neurotrophic signaling causing neurological decline.

Find out more about NeuroClimax, a recent intranasal nootropic spray formulations for cognitive, memory, and neuro-genesis enhancement against cognitive decline, brain aging, and metabolic fatigue.

Revolutionizing Minds,
Restoring Lives

Pioneering intranasal nootropics and therapeutics for enhanced brain wellness. Experience the future of brain health with our scientifically validated products.

About CNS Curative Technologies

At CNS Curative Technologies, we are dedicated to enhancing brain wellness through innovative intranasal nootropics and therapeutics. Our mission is to revolutionize brain health by offering solutions grounded in rigorous scientific research. Partnering with neurology clinics of Nevada and leveraging our collaborations with top institutions, we aim to transform the field of Nevada neurologic care.

Research and Innovation

Leading the Way in Brain Health Research

At CNS Curative Technologies, we are at the forefront of brain health research. Our collaboration with the Whittermore Petterson institute, the Whittermore Investment Group in Reno Nevada, and other prestigious institutions (Parkinson’s Disease Foundation) enables us to develop groundbreaking treatments. We are committed to advancing Nevada neurologic care through innovative research and clinical trials.

products in the Pipeline 1 launched product

0 +

Satisfied Clients

products in the Pipeline 1 launched product

0 +

Satisfied Clients

Benefits of NeuroClimax®

Reach the potential of your mind with NeuroClimax®.

Enhanced Cognitive Function

NeuroClimax® boosts cognitive function, enhancing memory, focus, and mental clarity through rapid intranasal absorption.

Safe and Scientifically Validated

NeuroClimax® is GMP-grade and scientifically validated, ensuring safe and effective cognitive enhancement without harmful side effects.

Convenient and User-Friendly

NeuroClimax® intranasal spray is portable and easy to use, offering convenient cognitive support wherever you go.

Our Advanced Cognitive Enhancement Solutions

Subscription offers

NeuroClimX MD is now launched!

A brain health innovation nootropic spray for brain energy against cognitive decline due to brain fog and brain fatigue

NeuroClimax Advanced Formulation Nootropic Spray

NeuroClimax's product performance on customers

The formulation nootropic spray has proprietary cognitive enhancer with organic pharmaceutical grade active ingredients. It potentiates memory, learning, cognitive enhancement, brain energy and focus through brain plasticity mechanisms in neurons. Nasal spray formulation increases the level of Cyclic AMP, Brain-Derived Neurotrophic Factor and Nerve Growth Factor, thus the increase brain energy by increasing the level of ATP, increase the formation of neuronal networks and circuits, and activate neuronal re-development and growth of new neurons by NGF.

Active ingredients: 99 percent pharmaceutical grade Cyclic AMP enhancers (up to 0.5 %) 99 percent pharmaceutical grade glutaminergic agonists of memory receptors peptides (up to 0.05%), Centrophenoxin Cholinergic potentiator (up to 1.7%).

Excipient: soothers, preservatives, and high brain availability active ingredients concentrators (natural gamma Cyclodextrants)

Recent developments on NeuroClimax's science and Technology

CNS Curative Technologies partners with advanced brain wellness gym for the brain to add NeuroClimax on their protocol

Gym for the Brain adds NeuroClimax® to Session Protocol

Ascend 2.0 business development grant for advanced development of formulation

Dr. Ruben Dagda of the University of Reno Nevada Selected for ASCEND2.0 Program to Advance Parkinson’s Disease Research

CNS Curative Technologies partners with Whittermore Petterson Institute on development of advanced nootropic technologies and patent against cognitive decline due to brain fog, brain fatigue

U.S. Provisional Patent Application No. 63/897,520
Title: TREATMENT OF COGNITIVE DECLINE AND FATIGUE WITH INTRANASAL NOOTROPIC FORMULATIONS
First Named Inventor: Raul Y. Dagda
CNS Curative Technologies LLC
Ref.: FHW081752

CNS / CT 001 is one of the intranasal nootropic formulations designed against Parkinson’s disease, in this preclinical science article published in the National Institute of Health describes how CNS / CT 001 increases neurotropic signaling to increase brain regenerative repair mechanisms, and new neuronal growth in brain in Parkinson’s disease rodent genetic models and eliminating brain aggregates in brain, the toxic proteins that kills neurons.

Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats – PMC

First preclinical publication on the administering of the intranasal compounds by intraperitoneal administration to genetic models of Parkinson’s disease rats increases neurotropic signaling for brain regenerative repair mechanisms, and new neuronal growth

Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats

Why Choose Us?

92.85% of clients reported
1 benefit

Customized therapies for optimum results and personalized care.

78.57% of clients reported
2 benefits

Leading in innovative therapies, backed by extensive clinical research and development.

64% of clients reported increased focus
1 hour

Holistic care approach ensuring well-rounded support and patient satisfaction.

71% of clients increased
energy 1 hour

Customized therapies for optimum results and personalized care.

50% of clients reported more productivity

Leading in innovative therapies, backed by extensive clinical research and development.

50% with motor symptom patients showed improvements in movement

EU clinics partnerships

Fisiokinesis at Greece Athens adds NeuroClimax, NeuroClimax Advanced nootropic formulation, and NeuroClimX MD into their clinical protocols

Testimonials

Here’s what our clients are saying about us.

Using NeuroClimax® has transformed my mornings. I feel more alert and energized throughout the day, with noticeable improvements in my memory and mood. A fantastic product for brain wellness!

Michael S.

I've struggled with brain fog for years, but NeuroClimax® has helped clear it up remarkably. I feel sharper and more capable in my daily tasks. Thank you, CNS Curative Technologies!

Emily L.

As someone managing Parkinson's disease, NeuroClimax® has provided much-needed relief. It's helped reduce my symptoms and enhance my overall well-being. I'm grateful for this innovative solution.

David P.

Offering Pioneering Advancements in Brain repair pharmaceutical technology against neurodegeneration

Revolutionizing Minds,
Restoring Lives

Pioneering intranasal nootropics and therapeutics for enhanced brain wellness. Experience the future of brain health with our scientifically validated products.

About CNS Curative Technologies

Leading the Way in Brain Health Research

products in the Pipeline 1 launched product

Satisfied Clients

products in the Pipeline 1 launched product

Satisfied Clients